149 related articles for article (PubMed ID: 36215205)
1. Impact and Recovery from COVID-19-Related Disruptions in Colorectal Cancer Screening and Care in the US: A Scenario Analysis.
van den Puttelaar R; Lansdorp-Vogelaar I; Hahn AI; Rutter CM; Levin TR; Zauber AG; Meester RGS
Cancer Epidemiol Biomarkers Prev; 2023 Jan; 32(1):22-29. PubMed ID: 36215205
[TBL] [Abstract][Full Text] [Related]
2. Prioritisation of colonoscopy services in colorectal cancer screening programmes to minimise impact of COVID-19 pandemic on predicted cancer burden: A comparative modelling study.
van Wifferen F; de Jonge L; Worthington J; Greuter MJE; Lew JB; Nadeau C; van den Puttelaar R; Feletto E; Yong JHE; Lansdorp-Vogelaar I; Canfell K; Coupé VMH;
J Med Screen; 2022 Jun; 29(2):72-83. PubMed ID: 35100894
[TBL] [Abstract][Full Text] [Related]
3. Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study.
de Jonge L; Worthington J; van Wifferen F; Iragorri N; Peterse EFP; Lew JB; Greuter MJE; Smith HA; Feletto E; Yong JHE; Canfell K; Coupé VMH; Lansdorp-Vogelaar I;
Lancet Gastroenterol Hepatol; 2021 Apr; 6(4):304-314. PubMed ID: 33548185
[TBL] [Abstract][Full Text] [Related]
4. Modelling optimal use of temporarily restricted colonoscopy capacity in a FIT-based CRC screening program: Application during the COVID-19 pandemic.
de Jonge L; van de Schootbrugge-Vandermeer HJ; Breekveldt ECH; Spaander MCW; van Vuuren HJ; van Kemenade FJ; Dekker E; Nagtegaal ID; van Leerdam ME; Lansdorp-Vogelaar I
PLoS One; 2022; 17(6):e0270223. PubMed ID: 35749423
[TBL] [Abstract][Full Text] [Related]
5. Impact of the COVID-19 Pandemic on Colorectal Cancer Screening: a Systematic Review.
Mazidimoradi A; Tiznobaik A; Salehiniya H
J Gastrointest Cancer; 2022 Sep; 53(3):730-744. PubMed ID: 34406626
[TBL] [Abstract][Full Text] [Related]
6. Cancer incidence and mortality in Australia from 2020 to 2044 and an exploratory analysis of the potential effect of treatment delays during the COVID-19 pandemic: a statistical modelling study.
Luo Q; O'Connell DL; Yu XQ; Kahn C; Caruana M; Pesola F; Sasieni P; Grogan PB; Aranda S; Cabasag CJ; Soerjomataram I; Steinberg J; Canfell K
Lancet Public Health; 2022 Jun; 7(6):e537-e548. PubMed ID: 35660215
[TBL] [Abstract][Full Text] [Related]
7. Projected long-term effects of colorectal cancer screening disruptions following the COVID-19 pandemic.
Nascimento de Lima P; van den Puttelaar R; Hahn AI; Harlass M; Collier N; Ozik J; Zauber AG; Lansdorp-Vogelaar I; Rutter CM
Elife; 2023 May; 12():. PubMed ID: 37129468
[TBL] [Abstract][Full Text] [Related]
8. COVID-related disruptions to colorectal cancer screening, diagnosis, and treatment could increase cancer Burden in Australia and Canada: A modelling study.
Worthington J; Sun Z; Fu R; Lew JB; Chan KKW; Li Q; Eskander A; Hui H; McLoughlin K; Caruana M; Peacock S; Yong JHE; Canfell K; Feletto E; Malagón T
PLoS One; 2024; 19(4):e0296945. PubMed ID: 38557758
[TBL] [Abstract][Full Text] [Related]
9. Colonoscopy screening and surveillance disparities during the COVID-19 pandemic.
Randle HJ; Gorin A; Manem N; Feustel PJ; Antonikowski A; Tadros M
Cancer Epidemiol; 2022 Oct; 80():102212. PubMed ID: 35816937
[TBL] [Abstract][Full Text] [Related]
10. What is the best screening strategy to detect advanced colorectal adenomas? Simulation from ongoing Italian screening experiences.
Ventura L; Zappa M; Carreras G; Ciatto S; Grazzini G
Tumori; 2011; 97(5):547-50. PubMed ID: 22158481
[TBL] [Abstract][Full Text] [Related]
11. Modelling the impacts of COVID-19 pandemic on the quality of population-based colorectal cancer screening.
Jen GH; Yen AM; Hsu CY; Chiu HM; Chen SL; Chen TH
Prev Med; 2021 Oct; 151():106597. PubMed ID: 34217416
[TBL] [Abstract][Full Text] [Related]
12. The impact of the rising colorectal cancer incidence in young adults on the optimal age to start screening: Microsimulation analysis I to inform the American Cancer Society colorectal cancer screening guideline.
Peterse EFP; Meester RGS; Siegel RL; Chen JC; Dwyer A; Ahnen DJ; Smith RA; Zauber AG; Lansdorp-Vogelaar I
Cancer; 2018 Jul; 124(14):2964-2973. PubMed ID: 29846933
[TBL] [Abstract][Full Text] [Related]
13. The impact of cumulative colorectal cancer screening delays: A simulation study.
Rutter CM; Inadomi JM; Maerzluft CE
J Med Screen; 2022 Jun; 29(2):92-98. PubMed ID: 34894841
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 Pandemic Had Minimal Impact on Colonoscopy Completion After Colorectal Cancer Red Flag Sign or Symptoms in US Veterans.
Demb J; Liu L; Bustamante R; Dominitz JA; Earles A; Shah SC; Gawron AJ; Martinez ME; Gupta S
Dig Dis Sci; 2023 Apr; 68(4):1208-1217. PubMed ID: 36169748
[TBL] [Abstract][Full Text] [Related]
15. Modelling the impact of the coronavirus pandemic on bowel cancer screening outcomes in England: A decision analysis to prepare for future screening disruption.
Mandrik O; Chilcott J; Thomas C
Prev Med; 2022 Jul; 160():107076. PubMed ID: 35526674
[TBL] [Abstract][Full Text] [Related]
16. The impact of episodic screening interruption: COVID-19 and population-based cancer screening in Canada.
Yong JH; Mainprize JG; Yaffe MJ; Ruan Y; Poirier AE; Coldman A; Nadeau C; Iragorri N; Hilsden RJ; Brenner DR
J Med Screen; 2021 Jun; 28(2):100-107. PubMed ID: 33241760
[TBL] [Abstract][Full Text] [Related]
17. Second-Look Colonoscopies and the Impact on Capacity in FIT-Based Colorectal Cancer Screening.
Grobbee EJ; Kapidzic A; van Vuuren AJ; van Leerdam M; Lansdorp-Vogelaar I; Looman CW; Bruno MJ; Kuipers EJ; Spaander MC
Am J Gastroenterol; 2015 Jul; 110(7):1072-7. PubMed ID: 26054624
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the effectiveness of two noninvasive fecal tests used to screen for colorectal cancer in average-risk adults.
Sharma T
Public Health; 2020 May; 182():70-76. PubMed ID: 32179290
[TBL] [Abstract][Full Text] [Related]
19. A delay in the diagnosis of colorectal cancer screened by fecal immunochemical tests during the COVID-19 pandemic: a longitudinal cohort study.
Ishibashi F; Shida D; Suzuki S; Nagai M; Mochida K; Morishita T
Int J Colorectal Dis; 2022 Dec; 37(12):2543-2546. PubMed ID: 36383225
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
